Back to Stock Universe
Daily Decision Engine
MARKSANSPHARMA
Marksans Pharma Ltd. · Healthcare · Pharma Research & Development · Small Cap
HOLD with net score +4 (+4 buy, −0 sell). Strongest positive: VR Stock Rating Strong (weight 4). P/E is 32% above its 5Y median — stretched vs history.
Engine Verdict
Hold
Score
+4
Buy
+4
Sell
−0
Veto
—
Price Context
Current Price
₹256.07
1M
+20.87%
1Y
+5.47%
3Y
+40.26%
5Y
+23.69%
52W Low ₹155.00Now ₹256.0752W High ₹275.50
Price History (Yahoo) with Your Decisions
No price data returned for this ticker.
Returns Profile
VR Score Radar (out of 10)
Verdict Breakdown · 1 triggered / 21 active
VR Stock Rating StrongBUYw4
VR Stock Rating (1-5) ≥ 4 → 4.00
P/E Below Its 5Y MedianBUYw2
P/E vs Median % < 0 → 31.73
Failed: P/E vs Median % = 31.73 is not < 0.
P/B Below Its 5Y MedianBUYw2
P/B vs Median % < 0 → 24.98
Failed: P/B vs Median % = 24.98 is not < 0.
VR Valuation Score StrongBUYw2
VR Valuation Score (1-10) ≥ 6 → 4.00
Failed: VR Valuation Score (1-10) = 4.00 is not ≥ 6.
Cheap on EV/EBITDABUYw2
EV / EBITDA < 12 → 15.52
Failed: EV / EBITDA = 15.52 is not < 12.
VR Proprietary Scores
VR Stock Rating
4 / 5 ⭐
Quality
7/10
Growth
6/10
Valuation
4/10
Momentum
8/10
Fundamentals
P/E
27.67
vs 5Y median 21.01 · +31.7%
P/B
3.83
vs 5Y median 3.06 · +25.0%
EV/EBITDA
15.52
Price / CFO
55.96
Price / Sales
3.92
PEG
2.41
From VR
Earning Yield %
5.37
From VR
Dividend Yield %
0.35
FCF / Share
1.98
→ FCF Yield 0.77%
EPS
9.22
Market Cap
11564.74 Cr
Enterprise Value
11252.20 Cr
Engine Zone Timeline · 2 runs
06-25+4
06-26+4
STRONG BUY
BUY
HOLD
SELL
STRONG SELL
AVOID
Your Decisions on MARKSANSPHARMA · 0
No decisions logged on this stock yet.
Use “Log Decision” above to start your trade journal. Every decision will appear here with hindsight grade.
Position Lifecycle · MARKSANSPHARMA
No position taken yet
You've only WATCHED / SKIPPED so far. Log a BUY decision to begin the lifecycle.
Recent News · MARKSANSPHARMA
No recent news found
Yahoo Finance returned no headlines for ticker MARKSANSPHARMA.NS.
If this ticker looks wrong (e.g. should be INFY.NS not INFOSYS.NS), open Symbol Aliases and set the correct Yahoo ticker.
Sector Peers
Comparing against 5 peers matched by sector: Pharma Research & Development
| Stock | Zone | Price | Mcap | P/E | P/B | ROE % | ROCE % | D/E | EPS g% | Div Y% | 1Y Ret % | Quality |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MARKSANSPHARMAYOU Marksans Pharma Ltd. | Hold | 256.07 | ₹116B | 27.67 | 3.83 | — | — | — | — | 0.35 | 5.47 | 7/10 |
| SUNPHARMACEUTICALIND Sun Pharmaceutical Industries Ltd. | Buy | 1,862.80 | ₹4.48T | 39.00 | 5.36 | — | — | — | — | 0.86 | 12.10 | 8/10 |
| CIPLA Cipla Ltd. | Hold | 1,440.10 | ₹1.17T | 30.18 | 3.41 | — | — | — | — | 0.90 | -4.15 | 8/10 |
| ZYDUSLIFESCIENCES Zydus Lifesciences Ltd. | Buy | 1,101.40 | ₹1.10T | 21.83 | 4.23 | — | — | — | — | 0.09 | 14.19 | 9/10 |
| GLAXOSMITHKLINEPHARM Glaxosmithkline Pharmaceuticals Ltd. | Hold | 2,354.80 | ₹398B | 38.44 | 17.44 | — | — | — | — | 2.43 | -27.08 | 10/10 |
| AJANTAPHARMA Ajanta Pharma Ltd. | Hold | 3,180.40 | ₹398B | 37.68 | 8.80 | — | — | — | — | 0.88 | 24.03 | 7/10 |
Green = peer is better than you on that metric (lower for valuation, higher for quality/growth). Click any peer to deep-dive.
AI Deep Dive (Claude)
Daily quota: 0 / 5
No AI analysis yet
Click 'Generate' to have Claude write a bull-case / bear-case / verdict-flip analysis using all the data on this page.
Ask Claude about this stock
Discuss MARKSANSPHARMA with AI0/30 today
Ask anything about MARKSANSPHARMA
I have your fundamentals, all 21 rule evaluations, recent analysis, and your decision journal in context.